SEATTLE--(BUSINESS WIRE)--May 16, 2012--Dendreon Corporation (NASDAQ:DNDN) today announced the following PROVENGE® (sipuleucel-T) data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place June 1-5, 2012 in Chicago, Illinois.
